F
Farmacosmo SpA
MIL:COSMO
Farmacosmo SpA
MIL:COSMO
Price:
0.487
EUR
0.21%
Market Cap:
€16.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
F
|
Farmacosmo SpA
MIL:COSMO
|
IT |
|
Oceanpal Inc
NASDAQ:SVRN
|
GR |
|
KISCO Corp
KRX:104700
|
KR |
|
O
|
O.B.System Inc
TSE:5576
|
JP |
|
Hemogenyx Pharmaceuticals PLC
LSE:HEMO
|
UK |
|
Green Envirotech Holdings Corp
OTC:GETH
|
US |
|
C
|
Corner Growth Acquisition Corp 2
NASDAQ:TRON
|
US |
|
Democrasoft Inc
OTC:DEMO
|
US |
Income Statement
Earnings Waterfall
Farmacosmo SpA
Farmacosmo SpA
Income Statement
Farmacosmo SpA
Farmacosmo SpA
Currency: EUR
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
|
| Revenue |
58
N/A
|
79
+35%
|
66
-16%
|
70
+7%
|
71
+1%
|
67
-6%
|
63
-6%
|
58
-8%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(55)
|
(74)
|
(63)
|
(67)
|
(67)
|
(63)
|
(59)
|
(55)
|
|
| Gross Profit |
4
N/A
|
5
+32%
|
2
-50%
|
3
+41%
|
4
+23%
|
4
+1%
|
4
+2%
|
3
-18%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(2)
|
(3)
|
(4)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(2)
|
(4)
|
(5)
|
(4)
|
(4)
|
(4)
|
|
| Depreciation & Amortization |
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Other Operating Expenses |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
1
N/A
|
2
+65%
|
(2)
N/A
|
(3)
-85%
|
(3)
-7%
|
(3)
+18%
|
(2)
+15%
|
(3)
-50%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
1
N/A
|
1
+83%
|
(2)
N/A
|
(4)
-73%
|
(4)
-12%
|
(3)
+19%
|
(3)
+9%
|
(5)
-50%
|
|
| Net Income | |||||||||
| Tax Provision |
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
0
|
1
|
(2)
|
(4)
|
(4)
|
(3)
|
(3)
|
(5)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
(0)
|
|
| Net Income (Common) |
0
N/A
|
1
+86%
|
(2)
N/A
|
(3)
-72%
|
(3)
+6%
|
(3)
+20%
|
(3)
-15%
|
(5)
-63%
|
|
| EPS (Diluted) |
0.01
N/A
|
0.02
+100%
|
-0.05
N/A
|
-0.1
-100%
|
-0.08
+20%
|
-0.06
+25%
|
-0.08
-33%
|
-0.12
-50%
|
|
Switch to:
Switch to:
See Also
Discover More
